From: A survey of severe asthma in Canada: results from the CASCADE practice reflective program
 | Never used a biologic (n = 152) | Biologic in the past (n = 26) | Currently using biologic (n = 325) | All patients (n = 503) |
---|---|---|---|---|
What asthma phenotype would you say this patient has? | ||||
 Allergic | 11% | 19% | 13% | 12% |
 Eosinophilic | 18% | 15% | 29% | 25% |
 Mixed | 48% | 58% | 54% | 53% |
 Non-type 2 | 20% | 4% | 4% | 9% |
 Other | 3% | 4% | 0% | 1% |
How many exacerbations requiring oral corticosteroids has the patient had in the past 12Â months? | ||||
 None | 28% | 35% | 45% | 39% |
 1 | 15% | 4% | 14% | 14% |
 2–3 | 46% | 46% | 31% | 36% |
 More than 3 | 11% | 15% | 10% | 11% |
Has the patient been hospitalized in the past 12Â months due to an asthma exacerbation? | ||||
 Yes | 14% | 15% | 13% | 14% |
 No | 85% | 81% | 86% | 86% |
 Unknown | 1% | 4% | 0% | 1% |
What is the patient's latest ACQ score? | ||||
 0 to < 0.75 | 3% | 4% | 13% | 9% |
 0.75 to < 1.5 | 5% | 0% | 9% | 7% |
 1.5 or more | 32% | 27% | 19% | 23% |
Not Available | 60% | 69% | 60% | 60% |
What is the patient's latest Sputum Eosinophils? | ||||
 < 3% | 2% | 0% | 2% | 2% |
 3% to 10% | 2% | 4% | 1% | 1% |
 > 10% | 1% | 4% | 2% | 2% |
 Not available | 95% | 92% | 95% | 95% |
What is the patient's latest FeNO? | ||||
 < 20 ppb | 5% | 8% | 10% | 9% |
 20 ppb or more | 14% | 19% | 15% | 15% |
 Not available | 81% | 73% | 75% | 77% |
What is the patient's latest FEV1? | ||||
 Median % of predicted | 70% | 69% | 78% | 75% |
 Median Volume | 2.0 L | 2.0 L | 2.2 L | 2.1 L |
 Not available | 9% | 12% | 7% | 8% |
What is the patient’s latest Skin Prick Test Result? | ||||
 Positive | 55% | 62% | 60% | 58% |
 Negative | 14% | 12% | 13% | 13% |
 Not available | 31% | 27% | 27% | 28% |
What is the patient's latest absolute blood eosinophil count? | ||||
 Mean | 354 cells/µL | 379 cells/µL | 479 cells/µL | 436 cells/µL |
 < 150 cells/µL | 29% | 19% | 30% | 29% |
 150 to < 300 cells/µL | 19% | 19% | 10% | 14% |
 > 300 cells/µL | 48% | 58% | 55% | 53% |
Not Available | 4% | 4% | 4% | 4% |